| Q35803459 | A Grape Seed Procyanidin Extract Ameliorates Fructose-Induced Hypertriglyceridemia in Rats via Enhanced Fecal Bile Acid and Cholesterol Excretion and Inhibition of Hepatic Lipogenesis |
| Q64259306 | A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol Levels |
| Q27693251 | A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport. |
| Q26865600 | A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion |
| Q28743016 | A reappraisal of the mechanism by which plant sterols promote neutral sterol loss in mice |
| Q57115936 | ABCG5 and ABCG8: more than a defense against xenosterols |
| Q35815267 | ABCG5/G8 deficiency in mice reduces dietary triacylglycerol and cholesterol transport into the lymph. |
| Q33894773 | Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice |
| Q37339259 | Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol |
| Q26801507 | Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL |
| Q47427721 | Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism |
| Q37013347 | Biliary and nonbiliary contributions to reverse cholesterol transport |
| Q34035681 | Biliary sterol secretion is not required for macrophage reverse cholesterol transport |
| Q33660599 | Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol |
| Q37236276 | Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport |
| Q61798396 | Dietary calcium affects body composition and lipid metabolism in rats |
| Q37716347 | Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice. |
| Q28073180 | Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training |
| Q35972634 | Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine |
| Q37662885 | Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice |
| Q37820951 | From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux. |
| Q53300754 | Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer. |
| Q37603238 | Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice. |
| Q80114730 | Hepatic Niemann-Pick C1-like 1: The canalicular side of the coin |
| Q27320737 | Hepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in mice |
| Q35014208 | Hepatic or intestinal ABCG5 and ABCG8 are sufficient to block the development of sitosterolemia |
| Q42398309 | Hypocholesterolaemic Activity of Lupin Peptides: Investigation on the Crosstalk between Human Enterocytes and Hepatocytes Using a Co-Culture System Including Caco-2 and HepG2 Cells |
| Q42150261 | In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1. |
| Q37382146 | Influence of class B scavenger receptors on cholesterol flux across the brush border membrane and intestinal absorption |
| Q37368738 | Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression. |
| Q36822555 | Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice |
| Q38234847 | Intestinal nuclear receptors in HDL cholesterol metabolism |
| Q57113485 | Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis |
| Q39710752 | Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model |
| Q37688760 | Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives |
| Q57125153 | Luminal plant sterol promotes brush border membrane-to-lumen cholesterol efflux in the small intestine |
| Q57132485 | Measurement of Intestinal and Peripheral Cholesterol Fluxes by a Dual-Tracer Balance Method |
| Q37662878 | Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport |
| Q34187966 | Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis. |
| Q55653252 | Para-bile-osis Establishes a Role for Nonbiliary Macrophage to Feces Reverse Cholesterol Transport. |
| Q42094173 | Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux |
| Q35838266 | Protein mediators of sterol transport across intestinal brush border membrane |
| Q36093336 | Recent advances in small bowel diseases: Part II. |
| Q41849738 | Reduction of VLDL secretion decreases cholesterol excretion in niemann-pick C1-like 1 hepatic transgenic mice |
| Q36007212 | Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies |
| Q34682311 | Reverse cholesterol transport is elevated in carboxyl ester lipase-knockout mice |
| Q37820949 | Reverse cholesterol transport: from classical view to new insights. |
| Q64237412 | Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability |
| Q36660888 | Role of the gut in lipid homeostasis |
| Q28299162 | Role of the intestinal bile acid transporters in bile acid and drug disposition |
| Q48556275 | Roux-en-Y gastric bypass reduces plasma cholesterol in diet-induced obese mice by affecting trans-intestinal cholesterol excretion and intestinal cholesterol absorption. |
| Q41833141 | Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex. |
| Q37707904 | Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse. |
| Q39782322 | Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss |
| Q36610558 | The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A. |
| Q64237427 | The TICE Pathway: Mechanisms and Lipid-Lowering Therapies |
| Q35850568 | The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance |
| Q27303091 | The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient mice |
| Q34428756 | Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport |
| Q42129050 | Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein. |
| Q36683297 | Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. |
| Q37033119 | Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux |
| Q36607669 | Trust your gut: galvanizing nutritional interest in intestinal cholesterol metabolism for protection against cardiovascular diseases |